UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
For the month of March 2017
Commission File Number: 001-36073
ENZYMOTEC LTD.
(Translation of registrant's name into English)
Sagi 2000 Industrial Area
P.O. Box 6
Migdal Ha'Emeq 2310001, Israel
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): __
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): __
CONTENTS
Results of Operations and Financial Condition
On February 22, 2017, Enzymotec Ltd. (NASDAQ: ENZY) (the “Company,” “we” or “us”) reported its unaudited financial results for the fourth quarter and full year ended December 31, 2016. A copy of the press release announcing those unaudited financial results is furnished as Exhibit 99.1 to this Report of Foreign Private Issuer on Form 6-K (this “Form 6-K”) and is incorporated herein by reference.
The information in Exhibit 99.1 to this Form 6-K shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| | EYZMOTEC LTD. | |
| | | | |
Dated: March 2, 2017 | By: | /s/ Oren Bryan | |
| | | Name: Oren Bryan | |
| | | Title: Chief Financial Officer | |
| | | | |
EXHIBIT INDEX
The following exhibit is furnished as part of this Form 6-K:
| Exhibit | | Description |
| 99.1 | | Press release dated February 22, 2017 announcing unaudited financial results of Enzymotec Ltd. for the fourth quarter and full year ended December 31, 2016 |
